Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Corline Biomedical

Corline Biomedical
1991 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
CLBIO STOCK SYMBOL
$1.55 SHARE PRICE (As of Friday Closing)
Description

Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Primary Office
  • Lefflersgatan 5
  • 754 50 Uppsala
  • Sweden

+46 018-71 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Corline Biomedical’s full profile, request a free trial.

Corline Biomedical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.29 - $2.54 $25.8M $1.56 -$0.06 13.7K 16.7M

Corline Biomedical Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 23,702 28,651 18,850 12,252
Revenue 128 180 75 111
EBITDA (976) (781) (914) (609)
Net Income (976) (781) (914) (612)
Total Assets 6,747 6,999 6,282 4,532
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Corline Biomedical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Corline Biomedical‘s full profile, request access.

Request full access to PitchBook

Corline Biomedical Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Corline Biomedical‘s full profile, request access.

Request full access to PitchBook